Additive Effect of Sarcopenia and Anemia on the 10-Year Risk of Cardiovascular Disease in Patients with Type 2 Diabetes
Objective. To investigate the association between sarcopenia and anemia and the 10-year cardiovascular disease risk in diabetic patients. Methods. A cross-sectional study was conducted involving 4673 hospitalized patients (2271 men and 2402 women) with type 2 diabetes mellitus, with an average age o...
Saved in:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2022-01-01
|
| Series: | Journal of Diabetes Research |
| Online Access: | http://dx.doi.org/10.1155/2022/2202511 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832564620970164224 |
|---|---|
| author | Feihui Zeng Lingning Huang Yongze Zhang Xinyu Hong Suiyan Weng Ximei Shen Fengying Zhao Sunjie Yan |
| author_facet | Feihui Zeng Lingning Huang Yongze Zhang Xinyu Hong Suiyan Weng Ximei Shen Fengying Zhao Sunjie Yan |
| author_sort | Feihui Zeng |
| collection | DOAJ |
| description | Objective. To investigate the association between sarcopenia and anemia and the 10-year cardiovascular disease risk in diabetic patients. Methods. A cross-sectional study was conducted involving 4673 hospitalized patients (2271 men and 2402 women) with type 2 diabetes mellitus, with an average age of 60.66±11.93 years, of whom 542 were followed up for a median follow-up period of 24 months. All participants underwent body composition measurements, and they were grouped by sex and presence of sarcopenia using the Framingham risk model to assess their 10-year cardiovascular risk. According to the changes in the cardiovascular risk during follow-up, the patients were divided into four groups: low-low, low-high, high-low, and high-high. Results. The prevalence of anemia was higher in the sarcopenia group than in the nonsarcopenia group (11.5% vs. 24.1% for men, P<0.001; 13.9% vs. 19.7% for women, P<0.05), and the difference remained significant after adjusting for confounders. Patients with sarcopenia and without anemia had a 46.2% increased risk of high 10-year cardiovascular disease (CVD) (odds ratio OR=1.462, 95% confidence interval (CI) 1.085–1.972, P=0.013), and the risk was twofold higher in patients with sarcopenia and anemia than in those without (OR=3.283, 95% CI 2.038–5.289, P<0.001). In follow-up studies, sarcopenia was associated with an increased risk of CVD at 10 years, and a reduction in appendicular skeletal muscle mass index independently predicted the increased risk of CVD. Conclusion. Sarcopenia is associated with an increased risk of anemia, and the presence of both has an additive effect on the 10-year CVD risk in patients with type 2 diabetes. Loss of muscle mass can independently predict an increased CVD risk in diabetic patients. |
| format | Article |
| id | doaj-art-8a5a6c847cb24db2b97a790aeb624c9e |
| institution | Kabale University |
| issn | 2314-6753 |
| language | English |
| publishDate | 2022-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Journal of Diabetes Research |
| spelling | doaj-art-8a5a6c847cb24db2b97a790aeb624c9e2025-02-03T01:10:37ZengWileyJournal of Diabetes Research2314-67532022-01-01202210.1155/2022/2202511Additive Effect of Sarcopenia and Anemia on the 10-Year Risk of Cardiovascular Disease in Patients with Type 2 DiabetesFeihui Zeng0Lingning Huang1Yongze Zhang2Xinyu Hong3Suiyan Weng4Ximei Shen5Fengying Zhao6Sunjie Yan7Department of EndocrinologyDepartment of EndocrinologyDepartment of EndocrinologyDepartment of EndocrinologyDepartment of EndocrinologyDepartment of EndocrinologyDepartment of EndocrinologyDepartment of EndocrinologyObjective. To investigate the association between sarcopenia and anemia and the 10-year cardiovascular disease risk in diabetic patients. Methods. A cross-sectional study was conducted involving 4673 hospitalized patients (2271 men and 2402 women) with type 2 diabetes mellitus, with an average age of 60.66±11.93 years, of whom 542 were followed up for a median follow-up period of 24 months. All participants underwent body composition measurements, and they were grouped by sex and presence of sarcopenia using the Framingham risk model to assess their 10-year cardiovascular risk. According to the changes in the cardiovascular risk during follow-up, the patients were divided into four groups: low-low, low-high, high-low, and high-high. Results. The prevalence of anemia was higher in the sarcopenia group than in the nonsarcopenia group (11.5% vs. 24.1% for men, P<0.001; 13.9% vs. 19.7% for women, P<0.05), and the difference remained significant after adjusting for confounders. Patients with sarcopenia and without anemia had a 46.2% increased risk of high 10-year cardiovascular disease (CVD) (odds ratio OR=1.462, 95% confidence interval (CI) 1.085–1.972, P=0.013), and the risk was twofold higher in patients with sarcopenia and anemia than in those without (OR=3.283, 95% CI 2.038–5.289, P<0.001). In follow-up studies, sarcopenia was associated with an increased risk of CVD at 10 years, and a reduction in appendicular skeletal muscle mass index independently predicted the increased risk of CVD. Conclusion. Sarcopenia is associated with an increased risk of anemia, and the presence of both has an additive effect on the 10-year CVD risk in patients with type 2 diabetes. Loss of muscle mass can independently predict an increased CVD risk in diabetic patients.http://dx.doi.org/10.1155/2022/2202511 |
| spellingShingle | Feihui Zeng Lingning Huang Yongze Zhang Xinyu Hong Suiyan Weng Ximei Shen Fengying Zhao Sunjie Yan Additive Effect of Sarcopenia and Anemia on the 10-Year Risk of Cardiovascular Disease in Patients with Type 2 Diabetes Journal of Diabetes Research |
| title | Additive Effect of Sarcopenia and Anemia on the 10-Year Risk of Cardiovascular Disease in Patients with Type 2 Diabetes |
| title_full | Additive Effect of Sarcopenia and Anemia on the 10-Year Risk of Cardiovascular Disease in Patients with Type 2 Diabetes |
| title_fullStr | Additive Effect of Sarcopenia and Anemia on the 10-Year Risk of Cardiovascular Disease in Patients with Type 2 Diabetes |
| title_full_unstemmed | Additive Effect of Sarcopenia and Anemia on the 10-Year Risk of Cardiovascular Disease in Patients with Type 2 Diabetes |
| title_short | Additive Effect of Sarcopenia and Anemia on the 10-Year Risk of Cardiovascular Disease in Patients with Type 2 Diabetes |
| title_sort | additive effect of sarcopenia and anemia on the 10 year risk of cardiovascular disease in patients with type 2 diabetes |
| url | http://dx.doi.org/10.1155/2022/2202511 |
| work_keys_str_mv | AT feihuizeng additiveeffectofsarcopeniaandanemiaonthe10yearriskofcardiovasculardiseaseinpatientswithtype2diabetes AT lingninghuang additiveeffectofsarcopeniaandanemiaonthe10yearriskofcardiovasculardiseaseinpatientswithtype2diabetes AT yongzezhang additiveeffectofsarcopeniaandanemiaonthe10yearriskofcardiovasculardiseaseinpatientswithtype2diabetes AT xinyuhong additiveeffectofsarcopeniaandanemiaonthe10yearriskofcardiovasculardiseaseinpatientswithtype2diabetes AT suiyanweng additiveeffectofsarcopeniaandanemiaonthe10yearriskofcardiovasculardiseaseinpatientswithtype2diabetes AT ximeishen additiveeffectofsarcopeniaandanemiaonthe10yearriskofcardiovasculardiseaseinpatientswithtype2diabetes AT fengyingzhao additiveeffectofsarcopeniaandanemiaonthe10yearriskofcardiovasculardiseaseinpatientswithtype2diabetes AT sunjieyan additiveeffectofsarcopeniaandanemiaonthe10yearriskofcardiovasculardiseaseinpatientswithtype2diabetes |